InvestorsObserver
×
News Home

Is Theseus Pharmaceuticals Inc (THRX) a Winner in the Biotechnology Industry?

Friday, December 22, 2023 09:43 AM | InvestorsObserver Analysts

Mentioned in this article

Is Theseus Pharmaceuticals Inc (THRX) a Winner in the Biotechnology Industry?

Theseus Pharmaceuticals Inc (THRX) is near the top in its industry group according to InvestorsObserver. THRX gets an overall rating of 63. That means it scores higher than 63 percent of stocks. Theseus Pharmaceuticals Inc gets a 80 rank in the Biotechnology industry. Biotechnology is number 49 out of 148 industries.

Overall Score - 63
THRX has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on THRX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Theseus Pharmaceuticals Inc Stock Today?

Theseus Pharmaceuticals Inc (THRX) stock is trading at $4.00 as of 9:38 AM on Friday, Dec 22, a gain of $0.30, or 8.11% from the previous closing price of $3.70. The stock has traded between $3.97 and $4.01 so far today. Volume today is below average. So far 226,578 shares have traded compared to average volume of 1,216,936 shares. Click Here to get the full Stock Report for Theseus Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App